Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| The Broad Institute, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
| The Broad Institute, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 7 | 1 |
| The Broad Institute, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
| The Broad Institute, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 9 | 1 |
| The Broad Institute, Inc., Medical Devices Deals, 2010 to YTD 2016 | 10 | 1 |
| The Broad Institute, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 11 | 2 |
| The Broad Institute, Inc., Pharmaceuticals &Healthcare, Deal Details | 13 | 29 |
| Partnerships | 13 | 1 |
| Cohen Veterans Bioscience Partners with Stanley Center for Psychiatric Research | 13 | 1 |
| Broad Institute Genomic Services Partners with Takeda Pharma | 14 | 1 |
| Beryllium Enters into Development Agreement with Broad Institute for MCL-1 platform | 15 | 1 |
| Bayer HealthCare Expands Co-Development Agreement with Broad Institute for Cardiovascular Therapies | 16 | 1 |
| AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute | 17 | 2 |
| Eisai Enters into Research Agreement with Broad Institute | 19 | 1 |
| Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics | 20 | 1 |
| EMD Serono Enters Into Research Agreement With Pfizer And Broad Institute | 21 | 2 |
| Massachusetts General Hospital Enters Into Collaboration Agreement With Broad Institute And Amgen For Drug Discovery | 23 | 2 |
| Eisai Enters Into Co-Development Agreement With Broad Institute For Neglected Tropical Diseases And Tuberculosis | 25 | 1 |
| Bayer HealthCare Pharma And Broad Institute Enter Into Agreement To Develop Cancer Therapy | 26 | 2 |
| AstraZeneca And Broad Institute Partner To Advance Discovery Of Antibacterial And Antiviral Agents | 28 | 1 |
| Licensing Agreements | 29 | 1 |
| Albany Molecular Research Enters into Licensing Agreement with Broad Institute | 29 | 1 |
| Evotec Enters into Licensing Agreement with Broad Institute | 30 | 1 |
| Transposagen Biopharma Enters into Licensing Agreement with Broad Institute | 31 | 1 |
| Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital | 32 | 1 |
| Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System | 33 | 1 |
| GE Healthcare Life Sciences Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System | 34 | 1 |
| Editas Medicine Enters into Licensing Agreement with Broad Institute of Harvard and MIT, and Harvard University | 35 | 2 |
| Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System | 37 | 1 |
| Sage Labs Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System | 38 | 1 |
| Applied Stemcell Enters into licensing Agreement with Broad Institute | 39 | 1 |
| Horizon Discovery Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System | 40 | 1 |
| ChemAxon Enters Into Licensing Agreement With Broad Institute Of Harvard And MIT | 41 | 1 |
| The Broad Institute, Inc. - Key Competitors | 42 | 1 |
| Key Employees | 43 | 1 |
| Locations And Subsidiaries | 44 | 1 |
| Head Office | 44 | 1 |
| Other Locations &Subsidiaries | 44 | 1 |
| Appendix | 45 | 1 |
| Methodology | 45 | 1 |
| About GlobalData | 45 | 1 |
| Contact Us | 45 | 1 |
| Disclaimer | 45 | 1 |